rs112829587

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_153252.5(BRWD3):​c.769G>A​(p.Val257Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000304 in 1,209,519 control chromosomes in the GnomAD database, including 2 homozygotes. There are 92 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0016 ( 1 hom., 46 hem., cov: 23)
Exomes 𝑓: 0.00017 ( 1 hom. 46 hem. )

Consequence

BRWD3
NM_153252.5 missense

Scores

2
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.560

Publications

3 publications found
Variant links:
Genes affected
BRWD3 (HGNC:17342): (bromodomain and WD repeat domain containing 3) The protein encoded by this gene contains a bromodomain and several WD repeats. It is thought to have a chromatin-modifying function, and may thus play a role in transcription. Mutations in this gene are associated with a spectrum of cognitive disabilities and X-linked macrocephaly. This gene is also associated with translocations in patients with B-cell chronic lymphocytic leukemia. [provided by RefSeq, Jul 2017]
BRWD3 Gene-Disease associations (from GenCC):
  • intellectual disability, X-linked 93
    Inheritance: XL, AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • X-linked syndromic intellectual disability
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • infantile spasms
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • self-limited epilepsy with centrotemporal spikes
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007643521).
BP6
Variant X-80744076-C-T is Benign according to our data. Variant chrX-80744076-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 198921.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 181 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BRWD3NM_153252.5 linkc.769G>A p.Val257Ile missense_variant Exon 8 of 41 ENST00000373275.5 NP_694984.5 Q6RI45-1
BRWD3NM_001441339.1 linkc.769G>A p.Val257Ile missense_variant Exon 8 of 40 NP_001428268.1
BRWD3XM_047441957.1 linkc.769G>A p.Val257Ile missense_variant Exon 8 of 38 XP_047297913.1
BRWD3XM_017029385.3 linkc.769G>A p.Val257Ile missense_variant Exon 8 of 22 XP_016884874.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BRWD3ENST00000373275.5 linkc.769G>A p.Val257Ile missense_variant Exon 8 of 41 1 NM_153252.5 ENSP00000362372.4 Q6RI45-1
BRWD3ENST00000478415.1 linkn.981G>A non_coding_transcript_exon_variant Exon 8 of 8 5

Frequencies

GnomAD3 genomes
AF:
0.00161
AC:
180
AN:
111629
Hom.:
1
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00580
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000957
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000404
AC:
74
AN:
183201
AF XY:
0.000207
show subpopulations
Gnomad AFR exome
AF:
0.00555
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000122
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000170
AC:
187
AN:
1097835
Hom.:
1
Cov.:
30
AF XY:
0.000127
AC XY:
46
AN XY:
363253
show subpopulations
African (AFR)
AF:
0.00538
AC:
142
AN:
26387
American (AMR)
AF:
0.0000568
AC:
2
AN:
35185
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19380
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54132
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40530
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4135
European-Non Finnish (NFE)
AF:
0.0000440
AC:
37
AN:
841812
Other (OTH)
AF:
0.000130
AC:
6
AN:
46078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
10
20
31
41
51
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00162
AC:
181
AN:
111684
Hom.:
1
Cov.:
23
AF XY:
0.00136
AC XY:
46
AN XY:
33878
show subpopulations
African (AFR)
AF:
0.00582
AC:
179
AN:
30754
American (AMR)
AF:
0.0000956
AC:
1
AN:
10460
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2654
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3575
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2679
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6012
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
215
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53129
Other (OTH)
AF:
0.00
AC:
0
AN:
1518
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000461
Hom.:
20
Bravo
AF:
0.00160
ESP6500AA
AF:
0.00548
AC:
21
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000445
AC:
54
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Oct 23, 2018
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 06, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Dec 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 08, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jun 22, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Intellectual disability, X-linked 93 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
16
DANN
Uncertain
1.0
DEOGEN2
Benign
0.097
T
FATHMM_MKL
Benign
0.22
N
LIST_S2
Benign
0.80
T
M_CAP
Benign
0.018
T
MetaRNN
Benign
0.0076
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.58
N
PhyloP100
0.56
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
-0.37
N
REVEL
Benign
0.096
Sift
Benign
0.55
T
Sift4G
Benign
0.16
T
Polyphen
0.65
P
Vest4
0.21
MVP
0.63
MPC
0.77
ClinPred
0.026
T
GERP RS
3.5
Varity_R
0.071
gMVP
0.12
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112829587; hg19: chrX-79999575; API